Register | Login or

General Information

Websitegbsventures.com.au
Phone61-3-8650-9900
Email
Employees
DescriptionLife science venture capital group

Funds

ABT, 8/98 $42.5M

Offices

Melbourne, AUS
Harley House, Level 5
71 Collins Street, Melbourne Vic 3000
Melbourne, AUS

People

Tags

GBS Ventures

GBS Venture Partners (GBS) is a leading life science venture capital group resulting from a November 2002 management buyout of Rothschild Bioscience Managers Limited from NM Rothschild & Sons (Aust) Ltd.

Milestones

Investments

Company Date Round Size Participants
Uptake Medical 2/12Series C$35M7
AirXpanders 1/12Series D$10M4
Spinifex Pharmaceuticals 8/11Series B$19M3
Pathway Therapeutics 5/11Series A$7.5M2
CoDa Therapeutics 4/11Series B$19.2M3
Euthymics Bioscience 3/11Series A$4M4
AirXpanders 3/11Unattributed$5M1
NeuroVista 8/10Unattributed$16.5M4
Nuon Therapeutics 8/10Unattributed$10M3
Pathway Therapeutics 8/10Series A$4.5M3
Euthymics Bioscience 7/10Series A$24M2
Uptake Medical 7/10Series B$17.5M6
Xenome 4/10Unattributed$10M2
Nuon Therapeutics 3/10Unattributed$6.05M3
Pathway Therapeutics 10/09Series A$2.4M2
KaloBios Pharmaceuticals 12/08Series D$12M8
Pathway Therapeutics 6/08Series A$9.6M2
NovaSys 5/08Unattributed$49.5M10
Nuon Therapeutics 7/07Series A$5M1
Phenomix 3/07Series C$55M10
OPAL Therapeutics 10/05Series A$6M4
Hatchtech 5/05Unattributed$2.2M5

Videos

Sources

  1. Citation Needed [add]
  2. Uptake Medical, Inc.: Series C $35M (onbiovc.com) [edit]
  3. AirXpanders Secures $10M in Series D Financing (airxpanders.com) [edit]
  4. Spinifex Closes AU$18.25M (~US$19M) Expanded Series B Round (spinifexpharma.com.au) [edit]
  5. FDA Approves Trial of Pathway Therapeutics, Inc. Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio (pathwaytx.com) [edit]
  6. CoDa Therapeutics Inks $19.2M Series B (pehub.com) [edit]
  7. Euthymics Bioscience bumps Series A to $28M (masshightech.com) [edit]
  8. AirXpanders raises $8M in 2 financings (bizjournals.com) [edit]
  9. NeuroVista Raises $16.5 Million in Equity Financing (neurovista.com) [edit]
  10. Nuon Therapeutics raises $10M in new funding (bizjournals.com) [edit]
  11. Pathway Therapeutics Completes $4.5 Million Financing for Novel PI3K Inhibitor Portfolio (pathwaytx.com) [edit]
  12. EUTHYMICS BIOSCIENCE, INC. CLOSES $24 MILLION SERIES A FINANCING AND COMPLETES ACQUISITION OF DOV PHARMACEUTICAL (euthymics.com) [edit]
  13. Uptake Medical Completes Series B Financing Round for $17.5 Million (uptakemedical.com) [edit]
  14. Xenome Completes A$10M Convertible Note Financing: Ongoing Support from Existing Venture Capital Investors - 22 April 2010 (xenome.com) [edit]
  15. Nuon captures $6.05M to develop treatments for autoimmune disease (deals.venturebeat.com) [edit]
  16. Pathway Therapeutics Completes $3Million Financing for Cancer Programs and appoints Dr Julie Cherrington as Chief Executive Officer (pathwaytx.com) [edit]
  17. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
  18. $10million for Pathway cancer drugs (pathwaytx.com) [edit]
  19. Novasys Medical takes $49.5M for women’s medical device (deals.venturebeat.com) [edit]
  20. Biotechnology Start-Up Nuon Therapeutics, Inc. Completes $5 Million Series A Financing And Names Management Team (nuontherapeutics.com) [edit]
  21. PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING (phenomixcorp.com) [edit]
  22. Opal Therapeutics raises $6m in series A funding (lifescientist.com.au) [edit]
  23. Hatchtech gets funding for head lice therapy. (goliath.ecnext.com) [edit]
Edit This Page
Last Edited 2/12/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy